Free Trial

TriMas' (TRS) "Buy" Rating Reiterated at BWS Financial

TriMas logo with Industrials background

Key Points

  • Analysts at BWS Financial raised the price target for TriMas from $40.00 to $45.00, indicating a potential upside of 24.58% based on the company's current stock price.
  • TriMas recently reported $0.61 earnings per share, surpassing the consensus estimate of $0.50, alongside a year-over-year revenue increase of 14.2%.
  • Insiders have recently purchased a significant amount of TriMas stock, with 848,261 shares acquired over the past three months, reflecting growing confidence in the company.
  • Looking to export and analyze TriMas data? Unlock 5 Weeks of MarketBeat All Access for Just $5. Claim Your Limited-Time Discount.

TriMas (NASDAQ:TRS - Get Free Report)'s stock had its "buy" rating reissued by BWS Financial in a report released on Wednesday, MarketBeat reports. They presently have a $45.00 price objective on the industrial products company's stock, up from their prior price objective of $40.00. BWS Financial's target price suggests a potential upside of 28.87% from the stock's current price. BWS Financial also issued estimates for TriMas' Q3 2025 earnings at $0.56 EPS, FY2025 earnings at $1.99 EPS, Q1 2026 earnings at $0.47 EPS and Q4 2026 earnings at $0.43 EPS.

Separately, Wall Street Zen raised TriMas from a "hold" rating to a "buy" rating in a research report on Sunday, June 1st.

Get Our Latest Stock Analysis on TriMas

TriMas Price Performance

NASDAQ:TRS traded down $0.81 during trading hours on Wednesday, reaching $34.92. The stock had a trading volume of 510,743 shares, compared to its average volume of 431,470. The stock has a market capitalization of $1.42 billion, a PE ratio of 38.37 and a beta of 0.66. The company has a debt-to-equity ratio of 0.59, a quick ratio of 1.44 and a current ratio of 2.59. The company has a 50 day moving average price of $28.94 and a two-hundred day moving average price of $25.29. TriMas has a 52 week low of $19.33 and a 52 week high of $36.77.

TriMas (NASDAQ:TRS - Get Free Report) last posted its quarterly earnings data on Tuesday, July 29th. The industrial products company reported $0.61 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.50 by $0.11. TriMas had a return on equity of 11.49% and a net margin of 3.83%. The company had revenue of $274.76 million during the quarter, compared to analysts' expectations of $251.18 million. During the same quarter in the previous year, the business earned $0.43 EPS. TriMas's revenue was up 14.2% compared to the same quarter last year. As a group, sell-side analysts anticipate that TriMas will post 1.69 earnings per share for the current fiscal year.

Insider Transactions at TriMas

In other news, Director Shawn Sedaghat acquired 410,172 shares of the business's stock in a transaction dated Wednesday, May 21st. The shares were acquired at an average cost of $25.43 per share, with a total value of $10,430,673.96. Following the completion of the acquisition, the director owned 1,810,821 shares of the company's stock, valued at approximately $46,049,178.03. This trade represents a 29.28% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the SEC, which is accessible through this link. Also, Director Adrianne Shapira acquired 4,000 shares of the business's stock in a transaction dated Thursday, June 5th. The stock was purchased at an average cost of $25.82 per share, for a total transaction of $103,280.00. Following the completion of the acquisition, the director directly owned 8,476 shares of the company's stock, valued at approximately $218,850.32. This trade represents a 89.37% increase in their position. The disclosure for this purchase can be found here. Insiders bought 848,261 shares of company stock worth $21,645,007 over the last three months. Corporate insiders own 14.20% of the company's stock.

Institutional Trading of TriMas

Hedge funds have recently modified their holdings of the stock. Sterling Capital Management LLC boosted its stake in shares of TriMas by 815.5% in the fourth quarter. Sterling Capital Management LLC now owns 1,300 shares of the industrial products company's stock worth $32,000 after buying an additional 1,158 shares during the last quarter. State of Wyoming purchased a new stake in shares of TriMas in the fourth quarter worth about $50,000. KLP Kapitalforvaltning AS purchased a new stake in shares of TriMas in the fourth quarter worth about $202,000. Apexium Financial LP purchased a new stake in shares of TriMas in the second quarter worth about $243,000. Finally, Comerica Bank boosted its stake in shares of TriMas by 214.5% in the first quarter. Comerica Bank now owns 11,119 shares of the industrial products company's stock worth $261,000 after buying an additional 7,584 shares during the last quarter. Hedge funds and other institutional investors own 99.42% of the company's stock.

About TriMas

(Get Free Report)

TriMas Corporation engages in the design, development, manufacture, and sale of products for consumer products, aerospace, and industrial markets worldwide. The company operates through Packaging, Aerospace, and Specialty Products segments. The Packaging segment offers dispensing products, such as foaming and sanitizer pumps, lotion and hand soap pumps, beverage dispensers, perfume sprayers, and nasal and trigger sprayers; polymeric and steel caps and closures comprising food lids, flip-top and beverage closures, child resistance caps, drum and pail closures, and flexible spouts; polymeric jar products; integrated dispensers; bag-in-box products; and consumable vascular delivery and diagnostic test components under the Rieke, Taplast, Affaba & Ferrari, Intertech, Omega, and Rapak brands.

Further Reading

Should You Invest $1,000 in TriMas Right Now?

Before you consider TriMas, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and TriMas wasn't on the list.

While TriMas currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Next Tech Boom: AI Robots Are Coming Sooner Than You Think!
Tech Stocks Stumble: Will Nvidia’s Report Spark a Rebound?
Follow the Money: 5 Stocks Institutions Are Buying NOW

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines